Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence

Br J Dermatol. 2020 Aug;183(2):380-382. doi: 10.1111/bjd.18957. Epub 2020 Mar 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Carcinoma, Squamous Cell* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Programmed Cell Death 1 Receptor
  • Skin Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors
  • Programmed Cell Death 1 Receptor